Recently in Topamax Category

May 8, 2011

Topamax May Alter Effectiveness Of Birth Control Pills

Recent reports indicate that in addition to problems such as cleft palates and cleft lip from taking Topamax, Topamax may cause oral contraceptives to loose their effectiveness.

Topamax (topiramate) is a popular migraine and seizure medication that has been recently revised by the FDA as a "Class D" pregnancy drug - i.e. one where significant evidence exists that the drug may cause harm to a fetus during pregnancy. Now, combined with evidence that Topamax may render certain birth control ineffective, physicians are urged to inform patients of the danger of Topamax and oral contraceptive interactions.

In addition to the potential for birth defects, patients taking Topamax have developed eye disorders such as glaucoma and acute myopia.

Continue reading "Topamax May Alter Effectiveness Of Birth Control Pills" »

April 19, 2011

Topamax Recall After Reports Of Unusual Odors

Johnson & Johnson has issued a Topamax recall after receiving complaints about an unusual odor linked to a byproduct from a chemical used in treating wood. Sources believe the contamination may have occurred as a result of the way medication is shipped and stored.

Topamax has recently come under fire after the FDA issued warnings of an increased risk of cleft lips and cleft palates in infants of mothers who take Topamax (topiramate) during pregnancy.

The FDA has given the Topamax a pregnancy risk rating of D, indicating positive evidence of human fetal risk and birth defects.

Topamax has also been linked to eye disorders such as blurred vision, acute myopia and secondary angle closure glaucoma.

Continue reading "Topamax Recall After Reports Of Unusual Odors" »